Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ajoa Asonye
Observed name:
Asonye, Ajoa
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
ORCID:
0009-0004-6609-5353
Observed ORCID:
0009-0004-6609-5353
OpenAlex ID:
A5117733726
Trends in US Pediatric Unintentional Nonprescription Cold and Cough, Analgesic and Antipyretic Drug Exposure Cases amid the COVID-19 Pandemic
2025
·
Sara Karami
, Christian Angelo I. Ventura
, et al.
·
Clinical Drug Investigation
·
4
PDF
Intentional pediatric nonprescription cold/cough and analgesic/antipyretic exposure trends amid the COVID-19 pandemic
2026
·
Sara Karami
, Christian Angelo I. Ventura
, et al.
·
Clinical Toxicology
·
1
Adult U.S. Poison Center Exposure Case Trends Involving Nonprescription Dextromethorphan Amid the COVID-19 Pandemic: a Quasi-experimental Interrupted Time Series Study
2026
·
Sara Karami
, Christian Angelo I. Ventura
, et al.
·
Journal of Medical Toxicology
Intentional pediatric nonprescription cold/cough and analgesic/antipyretic exposure trends amid the COVID-19 pandemic
2026
·
Karami, Sara
, Ventura, Christian Angelo I.
, et al.
·
Figshare
Show more works
View as search
Works count:
4
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type